VanEck Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.1M | Sell |
110,898
-4,028
| -4% | -$221K | 0.01% | 647 |
|
|
2025
Q1 | $8.13M | Buy |
114,926
+12,607
| +12% | +$891K | 0.01% | 542 |
|
|
2024
Q4 | $6.73M | Sell |
102,319
-29,813
| -23% | -$1.96M | 0.01% | 586 |
|
|
2024
Q3 | $9.25M | Sell |
132,132
-1,390
| -1% | -$97.3K | 0.01% | 468 |
|
|
2024
Q2 | $11M | Sell |
133,522
-9,315
| -7% | -$767K | 0.02% | 395 |
|
|
2024
Q1 | $12.5M | Buy |
142,837
+8,741
| +7% | +$763K | 0.02% | 353 |
|
|
2023
Q4 | $12.9M | Sell |
134,096
-20,975
| -14% | -$2.02M | 0.02% | 319 |
|
|
2023
Q3 | $13.7M | Sell |
155,071
-4,417
| -3% | -$391K | 0.03% | 300 |
|
|
2023
Q2 | $13.8M | Sell |
159,488
-5,349
| -3% | -$464K | 0.03% | 299 |
|
|
2023
Q1 | $16M | Sell |
164,837
-26,611
| -14% | -$2.59M | 0.04% | 276 |
|
|
2022
Q4 | $19.8M | Buy |
191,448
+53,398
| +39% | +$5.53M | 0.05% | 243 |
|
|
2022
Q3 | $11.7M | Sell |
138,050
-41,721
| -23% | -$3.54M | 0.03% | 288 |
|
|
2022
Q2 | $14.9M | Buy |
179,771
+23,834
| +15% | +$1.98M | 0.04% | 274 |
|
|
2022
Q1 | $12M | Buy |
155,937
+13,129
| +9% | +$1.01M | 0.02% | 337 |
|
|
2021
Q4 | $12.6M | Sell |
142,808
-6,167
| -4% | -$545K | 0.03% | 329 |
|
|
2021
Q3 | $11.5M | Sell |
148,975
-24,399
| -14% | -$1.89M | 0.03% | 330 |
|
|
2021
Q2 | $14.5M | Sell |
173,374
-8,946
| -5% | -$746K | 0.03% | 298 |
|
|
2021
Q1 | $13.8M | Sell |
182,320
-10,693
| -6% | -$807K | 0.04% | 289 |
|
|
2020
Q4 | $16.9M | Buy |
193,013
+23,265
| +14% | +$2.04M | 0.05% | 225 |
|
|
2020
Q3 | $12.9M | Sell |
169,748
-33,697
| -17% | -$2.56M | 0.04% | 227 |
|
|
2020
Q2 | $25.1M | Buy |
203,445
+41,280
| +25% | +$5.09M | 0.09% | 159 |
|
|
2020
Q1 | $13.7M | Sell |
162,165
-19,503
| -11% | -$1.65M | 0.07% | 179 |
|
|
2019
Q4 | $15.4M | Buy |
181,668
+2,474
| +1% | +$209K | 0.06% | 203 |
|
|
2019
Q3 | $12.1M | Sell |
179,194
-3,534
| -2% | -$238K | 0.06% | 203 |
|
|
2019
Q2 | $15.7M | Sell |
182,728
-17,510
| -9% | -$1.5M | 0.08% | 185 |
|
|
2019
Q1 | $17.8M | Buy |
200,238
+9,313
| +5% | +$827K | 0.09% | 171 |
|
|
2018
Q4 | $16.3M | Sell |
190,925
-18,430
| -9% | -$1.57M | 0.08% | 184 |
|
|
2018
Q3 | $20.3M | Buy |
209,355
+10,677
| +5% | +$1.04M | 0.1% | 180 |
|
|
2018
Q2 | $18.7M | Sell |
198,678
-38,734
| -16% | -$3.65M | 0.09% | 181 |
|
|
2018
Q1 | $19.2M | Sell |
237,412
-41,194
| -15% | -$3.34M | 0.1% | 171 |
|
|
2017
Q4 | $24.8M | Sell |
278,606
-83,901
| -23% | -$7.48M | 0.12% | 160 |
|
|
2017
Q3 | $33.7M | Buy |
362,507
+41,145
| +13% | +$3.83M | 0.17% | 121 |
|
|
2017
Q2 | $29.2M | Sell |
321,362
-11,421
| -3% | -$1.04M | 0.16% | 126 |
|
|
2017
Q1 | $29.2M | Buy |
332,783
+15,988
| +5% | +$1.4M | 0.13% | 131 |
|
|
2016
Q4 | $26.2M | Buy |
316,795
+36,542
| +13% | +$3.03M | 0.13% | 112 |
|
|
2016
Q3 | $25.9M | Sell |
280,253
-8,131
| -3% | -$752K | 0.12% | 111 |
|
|
2016
Q2 | $22.4M | Buy |
288,384
+21,418
| +8% | +$1.67M | 0.12% | 106 |
|
|
2016
Q1 | $22M | Sell |
266,966
-55,851
| -17% | -$4.61M | 0.15% | 119 |
|
|
2015
Q4 | $33.8M | Buy |
322,817
+71,513
| +28% | +$7.49M | 0.27% | 92 |
|
|
2015
Q3 | $26.5M | Sell |
251,304
-38,203
| -13% | -$4.02M | 0.2% | 109 |
|
|
2015
Q2 | $39.6M | Sell |
289,507
-12,097
| -4% | -$1.65M | 0.23% | 111 |
|
|
2015
Q1 | $37.6M | Sell |
301,604
-14,129
| -4% | -$1.76M | 0.22% | 108 |
|
|
2014
Q4 | $28.5M | Buy |
315,733
+43,571
| +16% | +$3.94M | 0.18% | 122 |
|
|
2014
Q3 | $19.6M | Sell |
272,162
-2,554
| -0.9% | -$184K | 0.1% | 147 |
|
|
2014
Q2 | $17.1M | Sell |
274,716
-73,010
| -21% | -$4.54M | 0.08% | 157 |
|
|
2014
Q1 | $23.7M | Buy |
347,726
+133,587
| +62% | +$9.11M | 0.12% | 132 |
|
|
2013
Q4 | $15.1M | Sell |
214,139
-56,701
| -21% | -$3.99M | 0.08% | 149 |
|
|
2013
Q3 | $19.5M | Buy |
270,840
+44,966
| +20% | +$3.25M | 0.1% | 109 |
|
|
2013
Q2 | $12.6M | Buy |
+225,874
| New | +$12.6M | 0.07% | 136 |
|